FIELD: medicine.
SUBSTANCE: patient suffering from drug-resistant hypertension has his/her systolic blood pressure and β-adrenergic responsiveness of red blood cell membranes measured. If the measured systolic blood pressure is 170 mm Hg or more, whereas the β-adrenergic responsiveness of red blood cell membranes is 40 standard units or more, radio-frequency renal sympathetic denervation is considered indicated. The systolic blood pressure of less than 170 mm Hg and the β-adrenergic responsiveness of red blood cell membranes of less than 40 standard units enables considering renal sympathetic denervation unnecessary.
EFFECT: method enables selecting the patients suffering from drug-resistant hypertension, who are in need of renal sympathetic denervation for reducing blood pressure effectively.
2 ex, 1 tbl
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD OF EVALUATING EFFECTIVENESS OF RADIOFREQUENCY SYMPATHETIC DENERVATION OF RENAL ARTERIES IN PATIENTS SUFFERING DRUG-RESISTANT ARTERIAL HYPERTENSION | 2015 | 
 | RU2578461C1 | 
| METHOD OF SELECTION OF PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION FOR CONDUCTING THE PROCEDURE OF SYMPATHETIC DENERVATION OF RENAL ARTERIES | 2017 | 
 | RU2658476C1 | 
| METHOD FOR PREDICTING THE LONG-TERM ANTIHYPERTENSIVE EFFICACY OF RENAL DENERVATION IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION | 2021 | 
 | RU2767134C1 | 
| METHOD FOR PREDICTING THE EFFECTIVENESS OF NEPHROPROTECTION IN SELECTING THE PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION ASSOCIATED WITH TYPE 2 DIABETES MELLITUS FOR THE SYMPATHETIC RENAL DENERVATION OF RENAL ARTERIES | 2019 | 
 | RU2728093C1 | 
| METHOD FOR PREDICTING THE EFFECTIVENESS OF THE PROCEDURE OF SYMPATHETIC RENAL DENERVATION OF RENAL ARTERIES IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION COMBINED WITH TYPE 2 DIABETES MELLITUS | 2021 | 
 | RU2772544C1 | 
| METHOD FOR PREDICTION OF IMPROVEMENT OF LEFT VENTRICULAR DIASTOLIC FUNCTION IN 6 MONTHS AFTER PROCEDURE OF SYMPATHETIC DENERVATION OF RENAL ARTERIES IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION COMBINED WITH TYPE 2 DIABETES MELLITUS | 2023 | 
 | RU2817191C1 | 
| METHOD FOR PREDICTING IMPROVEMENT OF RENAL HEMODYNAMICS 6 MONTHS AFTER PROCEDURE OF SYMPATHETIC DENERVATION OF RENAL ARTERIES IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION COMBINED WITH TYPE 2 DIABETES MELLITUS | 2023 | 
 | RU2807270C1 | 
| METHOD FOR PREDICTING THE EFFECTIVENESS OF THE RENAL DENERVATION PROCEDURE FOR THE SELECTION OF PATIENTS WITH ARTERIAL HYPERTENSION RESISTANT TO DRUG THERAPY IN ITS IMPLEMENTATION | 2020 | 
 | RU2750023C1 | 
| METHOD OF SELECTING PATIENTS WITH RESISTANT HYPERTENSION YOUNGER THAN 60 YEARS WITH DISTURBED CEREBRAL BLOOD FLOW RESERVE FOR SAFE AND EFFECTIVE TREATMENT BY RENAL DENERVATION | 2018 | 
 | RU2687009C1 | 
| METHOD FOR PREDICTION OF PRESERVATION OF RENAL PARENCHYMA VOLUME IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION FOR ONE YEAR AFTER RENAL DENERVATION | 2024 | 
 | RU2838306C1 | 
Authors
Dates
2015-09-20—Published
2014-12-18—Filed